Impax Asset Management Group PLC Bristol Myers Squibb CO Transaction History

Impax Asset Management Group PLC

$22.9 Billion
Q2 2024

A detailed history of Impax Asset Management Group PLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Impax Asset Management Group PLC holds 251,646 shares of BMY stock, worth $13.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

251,646

Previous 252,642 0.39%

Holding current value

$13.4 Million

Previous $13.7 Million 23.72%

% of portfolio

0.05%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$40.25 - $52.99 $40,089 - $52,778	-996 Reduced 0.39%	251,646 $10.5 Million
Q1 2024 Apr 30, 2024	BUY	$47.98 - $54.4 $3.2 Million - $3.63 Million	66,792 Added 35.94%	252,642 $13.7 Million
Q4 2023 Jan 26, 2024	SELL	$48.48 - $57.85 $4.47 Million - $5.33 Million	-92,216 Reduced 33.16%	185,850 $9.54 Million
Q3 2023 Nov 07, 2023	SELL	$57.89 - $64.73 $434,811 - $486,187	-7,511 Reduced 2.63%	278,066 $16.1 Million
Q2 2023 Aug 07, 2023	SELL	$63.71 - $70.74 $25.7 Million - $28.5 Million	-402,674 Reduced 58.51%	285,577 $18.3 Million
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $2.41 Million - $2.73 Million	36,679 Added 5.63%	688,251 $47.7 Million
Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $8.7 Million - $10.3 Million	127,114 Added 24.24%	651,572 $46.9 Million
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $20,382 - $12 Million	156,789 Added 42.64%	524,458 $37.3 Million
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $19.2 Million - $21.1 Million	-263,726 Reduced 41.77%	367,669 $28.3 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $4.81 Million - $5.77 Million	-78,223 Reduced 11.02%	631,395 $46.1 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $3.51 Million - $4.09 Million	65,395 Added 10.15%	709,618 $44.2 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $4.78 Million - $5.59 Million	80,722 Added 14.33%	644,223 $38.1 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $9.06 Million - $10.2 Million	152,621 Added 37.14%	563,501 $35.6 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $3.45 Million - $3.82 Million	60,000 Added 17.1%	410,880 $24.8 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $2.91 Million - $4.23 Million	62,800 Added 21.8%	350,880 $19.6 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $633,234 - $825,996	12,868 Added 4.68%	288,080 $18.5 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $3.71 Million - $4.11 Million	83,200 Added 43.33%	275,212 $12.5 Million
Q1 2019 May 13, 2019	BUY	$45.12 - $53.8 $8.66 Million - $10.3 Million	192,012 New	192,012 $9.16 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.

Account

Impax Asset Management Group PLC Bristol Myers Squibb CO Transaction History